A growing lab market doesn't lower the bar — it raises it

The intuitive assumption is that a growing market gets easier to enter — more competitors, more precedent, more well-worn paths to follow. In laboratory accreditation, growth tends to run the other way. As more testing labs, public-health labs and research groups chase the same ISO/IEC 17025 certificate, the same GLP compliance, the same grant funder’s approval, the boards and bodies granting all of it don’t lower the bar to keep up with volume. They raise it — because the bar is the only thing that keeps the credential worth having.

More labs chasing the same accreditation

Testing and public-health laboratory capacity has been expanding for years, driven by growth in manufacturing and export markets that require independent testing, by donor-funded public-health programmes standing up new diagnostic and reference labs, and by research funding that increasingly requires formal data-integrity compliance as a condition of the grant rather than a nice-to-have. That’s a genuinely good thing for the industry — more capacity, more labs able to participate in supply chains and research programmes that were previously closed to them.

It also means every accreditation body, every national board, every funder’s compliance office is reviewing a larger volume of applicants than it was five years ago, with review capacity that hasn’t grown at the same rate. Something has to give, and it’s rarely the standard itself — a certificate that gets easier to obtain as more labs seek it stops meaning what it’s supposed to mean to the customer, regulator or publication that relies on it downstream.

Why the criteria keep getting more specific

What actually happens instead is that the criteria get more precise, and the evidence required to satisfy them gets harder to fake convincingly at scale:

• Self-attestation gives way to derived evidence. A checklist someone filled in from memory the week before a visit doesn’t scale to a reviewer looking at hundreds of applicants a year, and it’s the easiest kind of evidence to get wrong without noticing. A readiness score computed live from a lab’s actual records scales, and it’s much harder to accidentally misrepresent.
• Narrative reports give way to structured submissions. Funders managing a growing portfolio of grantees are moving toward standardized digital evidence rather than PDF binders assembled by hand, for the same reason: a binder doesn’t scale to review, however good the lab behind it actually is.
• Spot checks give way to continuous verification. A board that can’t site-visit every applicant as often as it used to leans harder on evidence that proves itself between visits — a tamper-evident record rather than a document that only demonstrates integrity for as long as no one has quietly edited it since.

What this means for the labs in the middle

The lab this squeezes hardest is the one that would have cleared the bar comfortably five years ago with a spreadsheet and a paper trail, and hasn’t changed anything since. The bar moved under it. It’s now competing for the same accreditation slot, the same grant renewal, against labs that produce structured, independently verifiable evidence as a byproduct of how they already work — not as a scramble assembled in the weeks before a visit.

That’s the trend Archon’s compliance readiness and evidence-pack generation are built for: not because a checklist is worthless, but because a checklist is exactly the kind of evidence that stops being sufficient once a board is reviewing enough applicants that it has to be able to tell the real ones apart quickly. Pricing breaks down which tier fits a lab being assessed versus a lab whose software itself is part of what’s under review.